Im Zukunftspark 1
XENIOS has three brands of treatment devices with different emphases: novalung iLA for extended lung support, i-cor for synchronized cardiac assist and medos for customized products for surgery. All therapies are extracorporeal, i.e. support is external to the body. XENIOS products have applications with various acute and chronic diseases of the lungs and heart if the affected organs are no long independently functional. This includes chronic obstructive pulmonary disease (COPD), acute lung failure or circulatory collapse (cardiogenic shock) and cardiac surgery.